LSVMX
Price
$11.34
Change
+$0.19 (+1.70%)
Updated
Nov 21 closing price
Net Assets
24.31M
RWMHX
Price
$66.07
Change
+$0.64 (+0.98%)
Updated
Nov 21 closing price
Net Assets
204.09B
Interact to see
Advertisement

LSVMX vs RWMHX

Header iconLSVMX vs RWMHX Comparison
Open Charts LSVMX vs RWMHXBanner chart's image
LSV US Managed Volatility Institutional
Price$11.34
Change+$0.19 (+1.70%)
VolumeN/A
Net Assets24.31M
American Funds Washington Mutual R5E
Price$66.07
Change+$0.64 (+0.98%)
VolumeN/A
Net Assets204.09B
LSVMX vs RWMHX Comparison Chart in %
View a ticker or compare two or three
VS
LSVMX vs. RWMHX commentary
Nov 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSVMX is a Hold and RWMHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWMHX has more cash in the bank: 204B vs. LSVMX (24.3M). LSVMX pays higher dividends than RWMHX: LSVMX (2.87) vs RWMHX (1.33). LSVMX was incepted earlier than RWMHX: LSVMX (11 years) vs RWMHX (10 years). LSVMX (0.87) is less costly to investors than RWMHX (0.41). RWMHX is a more actively managed with annual turnover of: 29.00 vs. LSVMX (18.00). RWMHX has a lower initial minimum investment than LSVMX: RWMHX (250) vs LSVMX (100000). RWMHX annual gain was more profitable for investors over the last year : 3.42 vs. LSVMX (-5.04). RWMHX return over 5 years is better than : 44.31 vs. LSVMX (11.80).
LSVMXRWMHXLSVMX / RWMHX
Total Expense Ratio0.550.41134%
Annual Report Gross Expense Ratio0.870.41212%
Fund Existence11 years10 years-
Gain YTD12.2778.725141%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets24.3M204B0%
Annual Yield % from dividends2.871.33216%
Returns for 1 year-5.043.42-147%
Returns for 3 years-4.6527.82-17%
Returns for 5 years11.8044.3127%
Returns for 10 years34.9971.4749%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TARA7.260.82
+12.73%
Protara Therapeutics
ABT128.114.14
+3.34%
Abbott Laboratories
JXN93.842.02
+2.20%
Jackson Financial
RAPP27.250.40
+1.49%
Rapport Therapeutics Inc.
EDRY12.99N/A
N/A
EuroDry Ltd